Back to Newsroom

Tinghua Liquor Obtains European and U.S. Patents for Proprietary Distillation Processing Technology

International patent authorities recognize novel ingredient-editing process for distilled spirits

News provided by
Tinghua
September 30, 2026
5:12 am
EDT
Tinghua Liquor Obtains European and U.S. Patents for Proprietary Distillation Processing Technology / Source: Tinghua (EZ Newswire)
Tinghua Liquor Obtains European and U.S. Patents for Proprietary Distillation Processing Technology / Source: Tinghua (EZ Newswire)

YIBIN, China, September 30, 2026 (EZ Newswire) -- Qinghai Spring Medicinal Resources Technology Co., Ltd. today announced that its flagship beverage brand, Tinghua Liquor, has received official patent recognition from both European and United States intellectual property authorities for its proprietary spirit-processing technology.

The United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application Publication No. US 2024/0252453 A1, following a granted invention patent from the European Patent Office (EPO) under European Patent No. EP4353263 B1. The patent examinations conducted by European and U.S. authorities evaluated the technology strictly against established intellectual property criteria, including novelty, inventive step, and industrial applicability.

Precision Ingredient Engineering in Distilled Spirits

Traditional Baijiu brewing relies primarily on natural, open-air batch fermentation, which can lead to variance in trace compound composition. Tinghua’s patented processing system applies targeted ingredient-editing techniques — combining controlled-strain fermentation, molecular distillation, and membrane separation — to process aged liquor at the molecular level.

By utilizing modular compound identification and controlled separation, the technology aims to refine the trace chemical profile of distilled spirits. The process is designed to reduce specific volatile byproducts typically associated with harsh post-consumption discomfort while preserving the traditional full-bodied flavor profile of high-grade Baijiu.

Interdisciplinary Research Approach

Tinghua’s development framework combines traditional Chinese brewing methodologies with modern analytical food chemistry and neurophysiology concepts. The company’s research focuses on how specific trace congeners in distilled spirits interact with human sensory and physiological receptors during consumption.

About Tinghua

Ting Hua means “listening to the sound of liquor bubbles,” implying extraordinary Chinese Baijiu-making skills. As one of the world's six major distilled spirits, Chinese Baijiu enjoys a history of over 1,000 years. In ancient times, skilled spirit craftsmen determined the quality of spirits by checking the size and dissipation speed of bubbles when the spirits flowed into the barrel during distillation. Top artisans could even determine the spirits' quality by listening to the sound of the bubbles. With such amazing skills, we can study spirits in more ways to further understand the relationship between liquor and people. For more information, visit tinghuajiu.com.

About Qinghai Spring Medicinal Resources Technology Co., Ltd.

Qinghai Spring Medicinal Resources Technology Co., Ltd. (SSE: 600381) is an A-share listed healthcare and innovation enterprise headquartered in China. The company focuses on the modernization and technological transformation of traditional Chinese medicine resources, famously known for its research and development in high-efficiency Cordyceps sinensis (冬虫夏草) processing under brand initiatives such as "Verygrass" (极草). Expanding its portfolio, Qinghai Spring also applies traditional health theory and modern technology to luxury spirit development, including its flagship brand Tinghua Liquor (听花酒). Dedicated to scientific rigor, quality processing, and health advancement, Qinghai Spring strives to combine traditional wisdom with modern consumer wellness solutions. For more information, visit verygrass.com.

Disclaimer

The statements in this press release regarding potential health benefits, physiological responses, anti-inflammatory or antioxidant effects, and the prevention or treatment of disease have not been evaluated by the U.S. Food and Drug Administration (FDA) or European health authorities. Tinghua Liquor is an alcoholic beverage and is not intended to diagnose, treat, cure, or prevent any disease, including tumors. Patent application publication status indicates a pending intellectual property claim and does not constitute regulatory approval or endorsement of health claims by any governmental agency. Consumers should exercise moderation and follow established public health guidelines regarding alcohol consumption.

Media Contact

Jiande Li
lijiande@verygrass.com